Abstract:Hybrid positron emission tomography/magnetic resonance imaging (PET/MR) opens new possibilities in multimodal multiparametric (m2p) image analyses. But even the simultaneous acquisition of positron emission tomography (PET) and magnetic resonance imaging (MRI) does not guarantee perfect voxel-by-voxel co-registration due to organs and distortions, especially in diffusion-weighted imaging (DWI), which would be, however, crucial to derive biologically meaningful information. Thus, our aim was to optimize fusion and voxel-wise analyses of DWI and standardized uptake values (SUVs) using a novel software for m2p analyses. Using research software, we evaluated the precision of image co-registration and voxel-wise analyses including the rigid and elastic 3D registration of DWI and [18F]-Fluorodeoxyglucose (FDG)-PET from an integrated PET/MR system. We analyzed DWI distortions with a volume-preserving constraint in three different 3D-printed phantom models. A total of 12 PET/MR-DWI clinical datasets (bronchial carcinoma patients) were referenced to the T1 weighted-DIXON sequence. Back mapping of scatterplots and voxel-wise registration was performed and compared to the non-optimized datasets. Fusion was rated using a 5-point Likert scale. Using the 3D-elastic co-registration algorithm, geometric shapes were restored in phantom measurements; the measured ADC values did not change significantly (F = 1.12, p = 0.34). Reader assessment showed a significant improvement in fusion precision for DWI and morphological landmarks in the 3D-registered datasets (4.3 ± 0.2 vs. 4.6 ± 0.2, p = 0.009). Most pronounced differences were noted for the chest wall (p = 0.006), tumor (p = 0.007), and skin contour (p = 0.014). Co-registration increased the number of plausible ADC and SUV combinations by 25%. The volume-preserving elastic 3D registration of DWI significantly improved the precision of fusion with anatomical sequences in phantom and clinical datasets. The research software allowed for a voxel-wise analysis and visualization of [18F]FDG-PET/MR data as a "combined diffusivity-metabolic index" (cDMI). The clinical value of the optimized PET/MR biomarker can thus be tested in future PET/MR studies.

Die vielen verschiedenen Gesichter der MOGAD in der MRT: von FUEL bis FLAMES

Contents Vol. 199, 2014

Graphisches Inhaltsverzeichnis: Angew. Chem. 41/2021

Differentiation of MOGAD in ADEM-like Presentation Children Based on FLAIR MRI Features.

Macromol. Symp. 306–307

Werner-Porstmann-Preis

Graphisches Inhaltsverzeichnis: Angew. Chem. 8/2019

Graphisches Inhaltsverzeichnis: Angew. Chem. 40/2019

MAMMA – Brustkrebs: Mastektomieraten nach Screening-MRT, präoperativer und diagnostischer MRT

JUNGES FORUM – Lern-App trainiert Prostatakarzinomdiagnostik

Recommendations of the German Radiological Society's breast imaging working group regarding breast MRIAktualisierung der Empfehlungen der AG Mammadiagnostik der Deutschen Röntgengesellschaft zur Durchführung der Mamma-MRT

MAMMA – DWI-MRT vor und nach Kontrastmittelinjektion

Graphisches Inhaltsverzeichnis: Angew. Chem. 41/2019

HYBRID – PET/MRT beim Mammakarzinom: Verkürzung der Untersuchungszeit ohne Qualitätsverlust

Die Röntgen-Akademie

KOPF HALS – CEST-MRT zur Prognoseabschätzung bei diffusen Gliomen

Jetzt bewerben: Förderpreise der DEGUM-Sektion Kopf-Hals sowie der Arbeitskreise Bewegungsorgane und Mammasonografie

Graphisches Inhaltsverzeichnis: Angew. Chem. 52/2021

Gastrointestinale Onkologie: zentrale Rolle in Klinik und Forschung

Kommentar zu "KINDER – Lymphomstaging und -restaging mit der kontrastmittelfreien FDG-PET/MRT"

From Phantoms to Patients: Improved Fusion and Voxel-Wise Analysis of Diffusion-Weighted Imaging and FDG-Positron Emission Tomography in Positron Emission Tomography/Magnetic Resonance Imaging for Combined Metabolic-Diffusivity Index (cDMI)